In the fields of gene function research and drug development, BiOligo offers efficient, customized siRNA design and synthesis services to help researchers and drug developers achieve precise gene silencing. Our services include the design, optimization, and custom synthesis of siRNA sequences for different target genes, ensuring optimal experimental results.
Compared to traditional small molecule inhibitors, chemical drugs, and antibodies, siRNA offers the advantage of high specificity, enabling precise regulation of target gene expression. Bioligo leverages advanced design tools and algorithms to provide personalized siRNA design solutions, delivering high-quality synthesized products in a short time to support high-throughput screening and rapid experimental validation.
siRNA service | ||||
Application | Suitable for preliminary screening of RNAi in various cells | Increase siRNA stability and effectively inhibit target gene expression | Ensure ultra-high performance of silencing specificity, efficiency and stability of each siRNA sequence | Can be injected directly into the animal for systemic or partial drug delivery |
Features
High Efficacy: Our professional designs ensure >70% silencing efficiency. We target multiple regions of the same mRNA to enhance silencing success.
Guaranteed Performance: If all three siRNA pairs in a kit fail to achieve >70% silencing, we will provide one additional free pair for the target gene based on your experimental data (choose either 80% transfection efficiency or >70% interference effect).
Fast and Reliable: We deliver high-purity, stable siRNAs quickly, ensuring you can move forward with your experiments without delay.
Comprehensive Support: Our technical experts are available to help optimize designs and troubleshoot experimental challenges.
Service Details
S/N | Services | Specification |
PRsi001 | siRNA regular single-target synthesis | 2.5nmol |
PRsiu002 | UHP- siRNA chemical modified single-target synthesis | 2.5nmol |
PRsit003 | siRNA regular 1/3 package synthesis | 5nmol*3 |
PRsit003 | siRNA regular 2/5 package synthesis | 5nmol*5 |
PRsit004 | siRNA regular 1/3 ready-to-use package synthesis | 5nmol*3 |
PRsit004 | siRNA regular 2/5 Ready-to-Use Package Synthesis | 5nmol*5 |
Prsiut005 | UHP-siRNA chemical modified 1/3 package synthesis | 5nmol*3 |
Prsiut005 | UHP-siRNA chemical modified 2/5 package synthesis | 5nmol*5 |
Prsiut006 | UHP-siRNA chemical modified 1/3 ready-to-use package synthesis | 5nmol*3 |
Prsiut006 | UHP-siRNA chemical modified 2/5 ready-to-use package synthesis | 5nmol*5 |